Treace Medical Concepts (TMCI) Other Non Operating Income (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Other Non Operating Income came in at -$915000.0 in Q2 2026, down 115.8% on a YoY basis from $5.8 million in Q2 2025, and down 15.24% quarter-over-quarter from -$794000.0 in Q1 2026.
Powered by 
Analysis
Treace Medical Concepts (TMCI) Other Non Operating Income (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Other Non Operating Income for 7 consecutive years, with -$915000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income fell 115.8% year-over-year to -$915000.0; the trailing twelve-month figure through Jun 2026 stood at $379000.0 (up 129.45% YoY), and the FY2025 full-year result was -$4.8 million, down 8714.55% from the prior year.
- Other Non Operating Income slipped to -$915000.0 in Q2 2026 per TMCI's latest filing, from -$794000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.7 million in Q4 2025 and bottomed at -$5.3 million in Q2 2022.
- Historically, Other Non Operating Income has averaged -$361666.7 across 5 years, with a median of -$318500.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 413.66% in 2022, then surged 1009.09% in 2025.
- Over 5 years, Other Non Operating Income stood at -$915000.0 in 2022, then jumped by 154.75% to $501000.0 in 2023, then plunged by 159.28% to -$297000.0 in 2024, then soared by 1009.09% to $2.7 million in 2025, then plunged by 133.89% to -$915000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$915000.0, -$794000.0, and $2.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -915,000.00 |
| Mar 31, 2026 | -794,000.00 |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | -612,000.00 |
| Jun 30, 2025 | -424,000.00 |
| Mar 31, 2025 | -340,000.00 |
| Dec 31, 2024 | -297,000.00 |
| Sep 30, 2024 | -226,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Mar 31, 2024 | 292,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 297,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 322,000.00 |
| Dec 31, 2022 | -915,000.00 |
| Sep 30, 2022 | -815,000.00 |
| Jun 30, 2022 | -5.30 Mn |
| Mar 31, 2022 | -940,000.00 |
| Dec 31, 2021 | -1.02 Mn |
| Sep 30, 2021 | -958,000.00 |